ABX464

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2

ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

ABTECT - Maintenance

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

Phase 2b/3 Study of ABX464 in Moderate to Severe Active Crohn's Disease Patients

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

ABX464 First in Man Study

Safety and Pharmacokinetics Study in Healthy Japanese Volunteers

Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464

Safety, PK and PD Study of ABX464 in Untreated HIV Patients